HER2 enriched breast cancer subtype is hormone-receptor negative (ER−/PR−) and HER2 positive (HER2+) with high Ki67 index, incorporating around 20% of all the BC subtypes [20], and has been considered the subtype with the worst prognosis and lowest survival rate. This evidence concerns the gene ERBB2 and breast cancer.